| Literature DB >> 27536584 |
Young Wook Lim1, Myung Jin Kim1, Yong Suk Lee1, Yong Sik Kim1.
Abstract
PURPOSE: Patients who have secondary hip osteoarthritis as sequelae of Legg-Calvé-Perthes disease (LCPD) are severe deformities of femoral head and acetabulum. A few studies have presented that the clinical results and risks associated with total hip arthroplasty (THA) for patients with a history of LCPD were not satisfactory. In this study, we reported the radiographic and clinical outcomes of THA in patients with sequelae of LCPD.Entities:
Keywords: LCP Sequelae; Legg-Calvé-Perthes disease; Total hip arthroplasty
Year: 2014 PMID: 27536584 PMCID: PMC4971396 DOI: 10.5371/hp.2014.26.4.214
Source DB: PubMed Journal: Hip Pelvis ISSN: 2287-3260
Patient Data
Values are presented as number only or mean±standard deviation (range).
Bencox II® (Corentec, Seoul, Korea); Accolade® (Stryker, Kalamazoo, MI, USA).
Fig. 1(A) This anteroposterior radiography shows secondary osteoarthritis caused by sequelae of Legg-Calvé-Perthes disease in a 57-year-old male. (B) The immediate postoperative radiography shows good positioning of the prosthesis. (C) After 5 years, the radiograph shows no osteolysis around the right acetabular and femoral component, and stable components with proper bony ingrowth.
Fig. 2(A) This anteroposterior radiography shows secondary osteoarthritis caused by sequelae of Legg-Calvé-Perthes disease in a 35-year-old female. Preoperatively, leg length discrepancy was measured about 1.3 cm. (B) The immediate postoperative radiography shows that the affected limb was over-lengthened about 7 mm. The patients complained severe neurogenic pain on the affected leg, and motor weakness (Grade 0). (C) The total hip arthroplasty was revised with medicalization of acetabular cup and exchanging with smaller sized stem. Postoperatively, leg length discrepancy was not examined. (D) After 2 years, the radiograph shows no osteolysis around the right acetabular and femoral component, and the sciatic nerve palsy was improved (Grade IV).